EU withdraws marketing authorization for Tavneos (avacopan)

The European Medicines Agency withdraws the marketing authorization for Tavneos, a vasculitis treatment.

Published 3h1 sourceNotableupdated 1h

≈ 17sSpeed

The fact

Available batches are being urgently recalled across the European Union.

Affected patients are advised to consult their doctor for an alternative treatment.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 22, 2026